Rick Jaenisch went through treatment six times before his hepatitis C was cured in 2017. Each time his doctors recommended a different combination of drugs, his insurer denied the initial request ...
CHICAGO (WLS) -- Hepatitis C cases have been rising in recent years, significantly impacting women of childbearing age. Hepatitis C can cause low birthweight, liver disorders and pre-term births in an ...
Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the illness. Patients with moderate to severe ...
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...
How do viruses do their job of infecting humans? Some of them are experts at evading the immune system so that it won't knock them out. Take hepatitis C, a sneaky and potentially deadly viral ...
Hepatitis C is the most common blood-borne viral infection in the United States, with around 2.4 million people living with the disease. However, many people with the infection do not know that they ...
The Food and Drug Administration granted breakthrough therapy designation to a treatment regimen of two investigational drugs for patients with chronic hepatitis C virus who did not respond to ...
A new CDC report finds that just a third of those diagnosed with hepatitis C have cleared the virus — a decade after a cure was made available. Hepatitis C can be cured. So why aren't more people ...
Bashar A. Aqel, MD, Mayo Clinic, Phoenix, Arizona, presented results from phase 2 of the COSMOS (Combination Of SiMeprevir and sOfosbuvir in hepatitis C virus genotype 1 infected patients) trial. On ...
(Reuters) - Data from Achillion Pharmaceuticals Inc's hepatitis C drug trials showed the company could develop a shorter-duration treatment rivaling offerings from Gilead Sciences Inc and Abbvie Inc.
With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results